Archives of Medical Research
Volume 40, Issue 7 , Pages 551-560 , October 2009

DNA Copy Number Changes in Gastric Adenocarcinomas: High Resolution–Comparative Genomic Hybridization Study in Turkey

  • Güvem Gümüs-Akay

      Affiliations

    • Department of Medical Biology, Faculty of Medicine, Ankara University, Sihhiye, Ankara, Turkey
    • Corresponding Author InformationAddress reprint requests to: Güvem Gümüs Akay, Department of Medical Biology, Faculty of Medicine, Ankara University, 06100 Sihhiye, Ankara, Turkey; Phone: (+90) (312) 3103010/402; FAX: (+90) (312) 3106370
    • ,
  • Ali Ekrem Ünal

      Affiliations

    • Department of Surgical Oncology, Faculty of Medicine, Ankara University, Cebeci, Ankara, Turkey
    • ,
  • Atilla Halil Elhan

      Affiliations

    • Department of Biostatistics, Faculty of Medicine, Ankara University, Sihhiye, Ankara, Turkey
    • ,
  • Sancar Bayar

      Affiliations

    • Department of Surgical Oncology, Faculty of Medicine, Ankara University, Cebeci, Ankara, Turkey
    • ,
  • Kürsat Karadayι

      Affiliations

    • Department of Surgical Oncology, Faculty of Medicine, Ankara University, Cebeci, Ankara, Turkey
    • ,
  • Asuman Sunguroglu

      Affiliations

    • Department of Medical Biology, Faculty of Medicine, Ankara University, Sihhiye, Ankara, Turkey
    • ,
  • Ahmet Kadıkıran

      Affiliations

    • Department of Molecular Biology, Faculty of Science, Ankara University, Tandogan, Ankara, Turkey
    • ,
  • Ajlan Tükün

      Affiliations

    • Department of Medical Genetics, Faculty of Medicine, Ankara University, Sihhiye, Ankara, Turkey

Received 19 February 2009 ,Accepted 25 June 2009.

References 

  1. Dicken BJ, Bigam DL, Cass C, et al. Gastric adenocarcinoma: review and considerations for future directions. Ann Surg. 2005;241:27–39
  2. Lynch HT, Grady W, Suriano G, et al. Gastric cancer: new genetic developments. J Surg Oncol. 2005;90:114–133
  3. Stock M, Otto F. Gene deregulation in gastric cancer. Gene. 2005;360:1–19
  4. http://www.who.int/infobase/report.aspx?rid=119&iso=TUR&generateReport=Generate+Report (Retrieved February 08, 2009)
  5. Zheng L, Wang L, Ajani J, et al. Molecular basis of gastric cancer development and progression. Gastric Cancer. 2004;7:61–77
  6. Scartozzi M, Galizia E, Freddari F, et al. Molecular biology of sporadic gastric cancer: prognostic indicators and novel therapeutic approaches. Cancer Treat Rev. 2004;30:451–459
  7. Lapierre JM, Tachdjian G. Detection of chromosomal abnormalities by comparative genomic hybridization. Curr Opin Obstet Gynecol. 2005;17:171–177
  8. Kirchhoff M, Gerdes T, Rose H, et al. Detection of chromosomal gains and losses in comparative genomic hybridization analysis based on standard reference intervals. Cytometry. 1998;31:163–173
  9. O'Keefe CL, Tiu R, Gondek LP, et al. High-resolution genomic arrays facilitate detection of novel cryptic chromosomal lesions in myelodysplastic syndromes. Exp Hematol. 2007;35:240–251
  10. Noguchi T, Wirtz HC, Michaelis S, et al. Chromosomal imbalances in gastric cancer. Correlation with histologic subtypes and tumor progression. Am J Clin Pathol. 2001;115:828–834
  11. Hidaka S, Yasutake T, Kondo M, et al. Frequent gains of 20q and losses of 18q are associated with lymph node metastasis in intestinal-type gastric cancer. Anticancer Res. 2003;23:3353–3357
  12. Lee MH, Yang HY. Regulators of G1 cyclin-dependent kinases and cancers. Cancer Metastasis Rev. 2003;22:435–449
  13. Takada H, Imoto I, Tsuda H, et al. Screening of DNA copy-number aberrations in gastric cancer cell lines by array-based comparative genomic hybridization. Cancer Sci. 2005;96:100–110
  14. Han SU, Lee JH, Kim WH, et al. Significant correlation between serum level of hepatocyte growth factor and progression of gastric carcinoma. World J Surg. 1999;23:1176–1180
  15. van Dekken H, Alers JC, Riegman PH, et al. Molecular cytogenetic evaluation of gastric cardia adenocarcinoma and precursor lesions. Am J Pathol. 2001;158:1961–1967
  16. Morohara K, Nakao K, Tajima Y, et al. Analysis by comparative genomic hybridization of gastric cancer with peritoneal dissemination and/or positive peritoneal cytology. Cancer Genet Cytogenet. 2005;161:57–62
  17. Sakakura C, Mori T, Sakabe T, et al. Gains, losses, and amplifications of genomic materials in primary gastric cancers analyzed by comparative genomic hybridization. Genes Chromosomes Cancer. 1999;24:299–305
  18. Wu MS, Chang MC, Huang SP, et al. Correlation of histologic subtypes and replication error phenotype with comparative genomic hybridization in gastric cancer. Genes Chromosomes Cancer. 2001;30:80–86
  19. Peng DF, Sugihara H, Mukaisho K, et al. Alterations of chromosomal copy number during progression of diffuse-type gastric carcinomas: metaphase- and array-based comparative genomic hybridization analyses of multiple samples from individual tumours. J Pathol. 2003;201:439–450
  20. Kimura Y, Noguchi T, Kawahara K, et al. Genetic alterations in 102 primary gastric cancers by comparative genomic hybridization: gain of 20q and loss of 18q are associated with tumor progression. Mod Pathol. 2004;17:1328–1337
  21. Sonoda K, Miyamoto S, Yamazaki A, et al. Biologic significance of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) as a pivotal regulator of tumor growth through angiogenesis in human uterine cancer. Cancer. 2007;110:1979–1990
  22. Sonoda K, Miyamoto S, Nakashima M, et al. The biological role of the unique molecule RCAS1: a bioactive marker that induces connective tissue remodeling and lymphocyte apoptosis. Front Biosci. 2008;13:1106–1116
  23. Izumi M, Nakanishi Y, Yoshino I, et al. Expression of tumor-associated antigen RCAS1 correlates significantly with poor prognosis in nonsmall cell lung carcinoma. Cancer. 2001;92:446–451
  24. Nakamura Y, Yamazaki K, Oizumi S, et al. Expression of RCAS1 in human gastric carcinoma: a potential mechanism of immune escape. Cancer Sci. 2004;95:260–265
  25. Fukuda K, Tsujitani S, Maeta Y, et al. The expression of RCAS1 and tumor infiltrating lymphocytes in patients with T3 gastric carcinoma. Gastric Cancer. 2002;5:220–227
  26. Guan XY, Fu SB, Xia JC, et al. Recurrent chromosome changes in 62 primary gastric carcinomas detected by comparative genomic hybridization. Cancer Genet Cytogenet. 2000;123:27–34
  27. Sud R, Wells D, Talbot IC, et al. Genetic alterations in gastric cancers from British patients. Cancer Genet Cytogenet. 2001;126:111–119
  28. Buffart TE, Carvalho B, Mons T, et al. DNA copy number profiles of gastric cancer precursor lesions. BMC Genomics. 2007;8:345
  29. Morohara K, Tajima Y, Nakao K, et al. Gastric and intestinal phenotypic cell marker expressions in gastric differentiated-type carcinomas: association with E-cadherin expression and chromosomal changes. J Cancer Res Clin Oncol. 2006;132:363–375
  30. Lin MT, Lin BR, Chang CC, et al. IL-6 induces AGS gastric cancer cell invasion via activation of the c-Src/RhoA/ROCK signaling pathway. Int J Cancer. 2007;120:2600–2608
  31. Ashizawa T, Okada R, Suzuki Y, et al. Clinical significance of interleukin-6 (IL-6) in the spread of gastric cancer: role of IL-6 as a prognostic factor. Gastric Cancer. 2005;8:124–131
  32. Luo GQ, Li JH, Wen JF, et al. Effect and mechanism of the Twist gene on invasion and metastasis of gastric carcinoma cells. World J Gastroenterol. 2008;14:2487–2493
  33. Yan-Qi Z, Xue-Yan G, Shuang H, et al. Expression and significance of TWIST basic helix-loop-helix protein over-expression in gastric cancer. Pathology. 2007;39:470–475
  34. Cheng KW, Lahad JP, Kuo WL, et al. The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers. Nat Med. 2004;10:1251–1256
  35. Goldenring JR, Shen KR, Vaughan HD, et al. Identification of a small GTP-binding protein, Rab25, expressed in the gastrointestinal mucosa, kidney, and lung. J Biol Chem. 1993;268:18419–18422
  36. Huang Y, Prasad M, Lemon WJ, et al. Gene expression in papillary thyroid carcinoma reveals highly consistent profiles. Proc Natl Acad Sci USA. 2001;98:15044–15049
  37. Tong D, Czerwenka K, Heinze G, et al. Expression of KLF5 is a prognostic factor for disease-free survival and overall survival in patients with breast cancer. Clin Cancer Res. 2006;12:2442–2448
  38. Chen C, Benjamin MS, Sun X, et al. KLF5 promotes cell proliferation and tumorigenesis through gene regulation and the TSU-Pr1 human bladder cancer cell line. Int J Cancer. 2006;118:1346–1355
  39. Kwak MK, Lee HJ, Hur K, et al. Expression of Krüppel-like factor 5 in human gastric carcinomas. J Cancer Res Clin Oncol. 2008;134:163–167
  40. De Cat B, David G. Developmental roles of the glypicans. Semin Cell Dev Biol. 2001;12:117–125
  41. Williamson D, Selfe J, Gordon T, et al. Role for amplification and expression of glypican-5 in rhabdomyosarcoma. Cancer Res. 2007;67:57–65
  42. Yu W, Inoue J, Imoto I, et al. GPC5 is a possible target for the 13q31-q32 amplification detected in lymphoma cell lines. J Hum Genet. 2003;48:331–335
  43. Tsukamoto Y, Uchida T, Karnan S, et al. Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer. J Pathol. 2008;216:471–482
  44. Koo SH, Kwon KC, Shin SY, et al. Genetic alterations of gastric cancer: comparative genomic hybridization and fluorescence in situ hybridization studies. Cancer Genet Cytogenet. 2000;117:97–103
  45. Kang JU, Kang JJ, Kwon KC, et al. Genetic alterations in primary gastric carcinomas correlated with clinicopathological variables by array comparative genomic hybridization. J Korean Med Sci. 2006;21:656–665
  46. Sakakura C, Hagiwara A, Yasuoka R, et al. Amplification and over-expression of the AIB1 nuclear receptor co-activator gene in primary gastric cancers. Int J Cancer. 2000;89:217–223
  47. Lassmann S, Weis R, Makowiec F, et al. Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas. J Mol Med. 2007;85:293–304
  48. Zhao C, Yasui K, Lee CJ, et al. Elevated expression levels of NCOA3, TOP1, and TFAP2C in breast tumors as predictors of poor prognosis. Cancer. 2003;98:18–23
  49. Kim NG, Kim JJ, Ahn JY, et al. Putative chromosomal deletions on 9P, 9Q and 22Q occur preferentially in malignant gastrointestinal stromal tumors. Int J Cancer. 2000;85:633–638
  50. Wang D, Fang D, Luo Y, et al. Study of loss of heterozygosity at DCC and APC/MCC genetic loci of gastric cancer. Chin Med Sci J. 1999;14:107–111
  51. Wang LH, Kim SH, Lee JH, et al. Inactivation of SMAD4 tumor suppressor gene during gastric carcinoma progression. Clin Cancer Res. 2007;13:102–110
  52. Uchino S, Tsuda H, Noguchi M, et al. Frequent loss of heterozygosity at the DCC locus in gastric cancer. Cancer Res. 1992;52:3099–3102
  53. Nishizuka S, Tamura G, Terashima M, et al. Loss of heterozygosity during the development and progression of differentiated adenocarcinoma of the stomach. J Pathol. 1998;185:38–43
  54. Candusso ME, Luinetti O, Villani L, et al. Loss of heterozygosity at 18q21 region in gastric cancer involves a number of cancer-related genes and correlates with stage and histology, but lacks independent prognostic value. J Pathol. 2002;197:44–50
  55. van Grieken NC, Weiss MM, Meijer GA, et al. Helicobacter pylori-related and -non-related gastric cancers do not differ with respect to chromosomal aberrations. J Pathol. 2000;192:301–306

PII: S0188-4409(09)00130-1

doi: 10.1016/j.arcmed.2009.07.004

Archives of Medical Research
Volume 40, Issue 7 , Pages 551-560 , October 2009

Article Tools

* Image Usage & Resolution